newsfilter
← Latest News
GlobeNewswire·

argenx to Host Autoimmune Myositis R&D Webinar

June 23, 2026, 7:00 AM CET Amsterdam, the Netherlands – argenx ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, will host